Earnings call transcript: U.S. Antimony misses Q3 2026 estimates as shares fall

U.S. Antimony reported a narrower-than-expected third-quarter loss but fell short of revenue estimates, causing its shares to drop in after-hours trading. The company posted a loss of 6 cents per share, exceeding analysts' projections of 2 cents, while revenue came in at $10.13 million, below the anticipated $16.72 million. Despite a 68% year-over-year increase in antimony sales volumes, the stock declined 6.73% in regular trading and another 8.93% in after-hours trading, reaching a low near its 52-week range.

Revenue rose 16% year-over-year and 28% sequentially, while gross profit more than doubled and gross margin expanded to 42% from 23%. The company's cash reserves stood at $51 million, and it had no debt drawn. Management adjusted guidance to volume-based due to antimony price volatility, and the company expects 2026 sales of 1.68 million to 1.81 million pounds, up 24% from 2025.